If you have any other questions or need other size, please get a quote.
Product Description
Documents
Case Study
Custom Reviews
Custom Q&A
Synthetic Use
Related Resources
Specification
Description
CZC-54252 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2) with IC50 values 1.28 nM and 1.85 nM for wild-type and G2019S mutant forms of LRRK2 respectively. CZC-54252 attenuates neuronal injury induced by LRRK2-G2019S mutant activity in primary human neurons (EC50 = 1 nM). Activating mutations in leucine-rich repeat kinase 2 (LRRK2) are present in a subset of Parkinson's disease (PD) patients and may represent an attractive therapeutic target.
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Alternative CAS
1784253-05-9 (HCl) 1191911-27-9 (free base)
Drug Formulation
To be determined
Elemental Analysis
C, 48.80; H, 4.84; Cl, 13.09; N, 15.52; O, 11.82; S, 5.92
HS Tariff Code
2934.99.9001
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).